Academic
Academic Work & Publications
Articles, conference papers, book chapters, clinical trials and awards.
Academic profile
Academic identity
Information on the academic and clinical experience of Assoc. Prof. Dr. Ali Oğul, including areas of work, academic identity and current publication records, is updated regularly. The list below is compiled from the records of the Mersin University Academic Staff Information System (APBS); for the most current full list, see the ORCID and APBS profiles.
- ORCID0000-0003-4886-7060
- Researcher IDAAO-7285-2021
- APBSMersin University profile
- UnitFaculty of Medicine · Department of Internal Medicine · Medical Oncology
- PubMedOgul A [Author]
- 46Articles
- 26Conference papers
- 9Clinical trials and projects
- 5Book chapters
Compiled from Mersin University APBS records (updated: 01.09.2026).
Articles 46
Articles published in international and national peer-reviewed journals, ordered by year. DOI links lead to the source of the publication.
2026
- 2026
Awareness and attitudes toward cytoreductive surgery and hyperthermic intraperitoneal chemotherapy among surgical and medical oncologists
Scientific Reports SCI-Expanded · Q1
DOI: 10.1038/s41598-026-43750-y - 2026
First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score
Medicina (Lithuania), 62(8), 1470
DOI: 10.3390/medicina62081470 - 2026
Prognostic significance of PET/CT-derived metabolic heterogeneity indices in wild-type metastatic colorectal cancer
Cukurova Medical Journal, 51(1), 206–216
DOI: 10.17826/cumj.1839084
2025
- 2025
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma
Medicina (Lithuania), 61(8), 1370 SCI-Expanded · Q1
DOI: 10.3390/medicina61081370 - 2025
Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer
Revista da Associação Médica Brasileira, 71(5) SCI-Expanded · Q2
DOI: 10.1590/1806-9282.20241408 - 2025
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI
Biomarkers in Medicine, 19(17), 1–9 SCI-Expanded · Q3
DOI: 10.1080/17520363.2025.2560797 - 2025
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
Scientific Reports, 15(1), 3200 SCI-Expanded · Q1
DOI: 10.1038/s41598-025-87553-z - 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study
Current Oncology, 32(11), 639–639 SCI-Expanded · Q2
DOI: 10.3390/curroncol32110639
2023
- 2023
A new prognostic index associated with pathological complete response in rectal cancer
Cukurova Medical Journal, 48(2), 575–582 ESCI: Emerging Sources Citation Index
DOI: 10.17826/cumj.1279880 - 2023
Effects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer
Revista da Associação Médica Brasileira, 69(1), 153–158 SCI-Expanded
DOI: 10.1590/1806-9282.20221123 - 2023
Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer
Journal of Cancer Research and Therapeutics, 20(1), 285–288 SCI-Expanded
DOI: 10.4103/jcrt.jcrt_1858_22 - 2023
Relationship of the Hemoglobin/Red Cell Distribution Width Ratio and Inflammatory Biomarkers with Prognosis in Nasopharyngeal Cancer
Eurasian Journal of Medical Investigation EBSCO
DOI: 10.14744/ejmi.2023.30252 - 2023
Brigatinib-associated autoimmune hepatitis: A case report
Journal of Oncology Pharmacy Practice, 32(4), 754–756 SCI-Expanded
DOI: 10.1177/10781552231171322
2022
- 2022
Panitumumab Associated Acute Pancreatitis
Journal of Oncology Pharmacy Practice, 28(5), 1207–1208 SCI-Expanded
DOI: 10.1177/10781552221073997 - 2022
Sarcoma – correlation between CD73 and PD-L1 and their relationship with prognosis
Polish Journal of Pathology, 73(4), 338–342 SCI-Expanded · Q4
DOI: 10.5114/pjp.2022.125537
2021
- 2021
The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer
Journal of BUON, 26(3), 1–10 SCI-Expanded · Q4
- 2021
Carotid-femoral pulse wave velocity is significantly increased in newly diagnosed hypertensive patients with primary hyperparathyroidism and significantly related with serum calcium level
Journal of Ultrasound, 24(4), 439–446 Emerging Sources Citation Index (ESCI)
DOI: 10.1007/s40477-020-00512-4 - 2021
Abiraterone Acetate–Associated Acute Pancreatitis: A Case Report
American Journal of Therapeutics, 30(3), e296–e298 SCI-Expanded
DOI: 10.1097/mjt.0000000000001381 - 2021
The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen
Journal of Gastrointestinal Cancer, 52(1), 249–255 Emerging Sources Citation Index
DOI: 10.1007/s12029-020-00396-x - 2021
Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers
Journal of Gastrointestinal Cancer, 52(1), 294–299 Emerging Sources Citation Index
DOI: 10.1007/s12029-020-00428-6
2020
- 2020
New-Generation Anaplastic Lymphoma Kinase Inhibitor Experience in a Case With Non–Small Cell Lung Cancer: High Efficacy but Unexpected Toxicity
American Journal of Therapeutics, 28(6), e799–e801 SCI-Expanded
DOI: 10.1097/mjt.0000000000001115 - 2020
Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy
Medical Science and Discovery, 7(5), 475–481 INDEX COPERNİCUS
DOI: 10.36472/msd.v7i5.374 - 2020
Dynamic prognostic nutritional index could be a novel predictor of survival in lung cancer patients treated with nivolumab
Annals of Clinical and Analytical Medicine, 11(Suppl_1), 1–6 Emerging Sources Citation Index (ESCI)
DOI: 10.4328/acam20025 - 2020
Inflammatory markers and clinical factors which affecting the survival in metastatic renal cell carcinoma
Medical Science and Discovery, 7(4), 459–465 INDEX COPERNİCUS
DOI: 10.36472/msd.v7i4.370 - 2020
Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases
Turkish Journal of Hematology, 37(4), 220–225 SCI-Expanded
- 2020
Factors predicting prognosis of oncology patients followed in the intensive care unit
Cukurova Medical Journal, 45(4), 1267–1275 Emerging Sources Citation Index (ESCI)
DOI: 10.17826/cumj.789199 - 2020
Dose-Adjusted R-EPOCH Therapy for Aggressive Lymphoma: A single center experience
Medical Science and Discovery, 7(11), 691–695 INDEX COPERNİCUS
DOI: 10.36472/msd.v7i11.438 - 2020
Efficacy of Prephase Treatment for the Prevention of Tumor Lysis Syndrome in Lymphoma Cases with High Tumor Burden: A Cross-Sectional Study
International Journal of Hematology and Oncology, 30(2), 87–93 SCI-Expanded
DOI: 10.4999/uhod.204157 - 2020
Prognostic signficance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer
Journal of BUON, 25(1), 159–167 SCI-Expanded
- 2020
Metastatik Meme Kanserli Hastaların Klinik Özellikleri ve Tedavi Sonuçları: Tek Merkez Deneyimi
Anadolu Kliniği Tıp Bilimleri Dergisi, 25(2), 75–80 TR DİZİN
DOI: 10.21673/anadoluklin.641856 - 2020
Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy
European Journal of Breast Health, 16(4), 229–234 TR DİZİN
DOI: 10.5152/ejbh.2020.5556 - 2020
LENFOMA HASTALARINDA HEPATİT B VE C PREVALANSININ DEĞERLENDİRİLMESİ
Namık Kemal Tıp Dergisi, 8(1), 48–51 TR DİZİN
DOI: 10.37696/nkmj.632911 - 2020
Predictive Biomarkers in Late Onset Neutropenia (LON) Associated with Rituximab
Eurasian Journal of Medical Investigation, 4(4), 428–432 TR DİZİN
DOI: 10.14744/ejmi.2020.55639
2019
- 2019
Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
Cancer Management and Research, 11(23), 3445–3453 SCI-Expanded
DOI: 10.2147/cmar.s191199 - 2019
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC)
International Journal of Clinical Oncology, 24(2), 168–178 SCI-Expanded
DOI: 10.1007/s10147-018-1338-8 - 2019
Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey
Balkan Journal of Medical Genetics, 22(2), 17–24 SCI-Expanded
DOI: 10.2478/bjmg-2019-0016 - 2019
Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma
Turkish Journal of Hematology, 36(1), 60–61 SCI-Expanded
DOI: 10.4274/tjh.galenos.2018.2018.0115 - 2019
Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI)
Acta Oncologica Turcica, 52(3), 372–378 TR DİZİN
DOI: 10.5505/aot.2019.08760 - 2019
LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGE INSTITUTION
Namık Kemal Tıp Dergisi, 7(3), 271–278 TR DİZİN
- 2019
Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer
3(1), 47–47
DOI: 10.14744/ejmo.2019.2019
2018
- 2018
Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature
Journal of Oncological Sciences (JOS), 4(1), 56–59 INDEX COPERNİCUS
DOI: 10.1016/j.jons.2018.03.002 - 2018
Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After Radioactive Iodine: A Case Report
Balkan Medical Journal, 35(2), 199–202 SCI-Expanded
DOI: 10.4274/balkanmedj.2017.0600 - 2018
G-CSF related hemophagocytosıs in a case with lymhphoma
Clinical Research and Trials, 4(1), 1–2 Not indexed
DOI: 10.15761/crt.1000203 - 2018
Metastatic Renal Cell Carcinoma Case Report Undergoing Multiple Treatment Options and Review of Literature
Eurasian Journal of Medical Investigation, 2(2), 101–103 Index Copernicus
DOI: 10.14744/ejmi.2018.76376
2017
- 2017
The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer
Journal of Gastrointestinal Cancer, 48(3), 286–287
DOI: 10.1007/s12029-017-9970-5
2016
- 2016
Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
Annals of Hematology, 95(1), 145–146 SCI-Expanded
DOI: 10.1007/s00277-015-2493-x
Conference papers 26
Papers presented at 6 international and 20 national congresses or symposia.
- 2024
Lenvatinib İlişkili Nöropati: Bir Olgu Sunumu ve Literatür Taraması
8.Uluslararası Sağlık Bilimleri ve Aile Hekimliği Kongresi (14.03.2024 – )
Ali Oğul · Abstract · Oral presentation
- 2021
HER2 POZİTİF MEME KANSERİNDE NEOADJUVANT TEDAVİYE PATOLOJİK YANITI BELİRLEYEN KLİNİKOPATOLOJİK FAKTÖRLER
4. GENÇLERLE ONKOLOJİYE BAKIŞ KONGRESİ (12.02.2021 – 14.02.2021)
Ali Oğul, Mahmut Büyükşimşek · Abstract · Oral presentation
- 2020
Malign Melanom Hastalarında D Vitamini Düzeylerinin İncelenmesi
3rd International Hippocrates Congress on Medical and Health Sciences (06.03.2020 – 07.03.2020)
Ali Oğul, Mahmut Büyükşimşek · Abstract · Oral presentation
- 2020
Ağız Ve Orofarenks Yerleşimli Non-Hodgkin Lenfomada Tek Merkez Deneyimi
19th International Eastern Mediterranean Family Medicine Congress (17.09.2020 – 20.09.2020)
Ali Oğul, Mahmut Büyükşimşek · Abstract · Oral presentation
- 2020
Neoadjuvan Kemoterapi Alan Meme Kanseri Hastalarında EZH2 ve MUC-1 Ekspresyonlarının Patolojik Tam Yanıt ile İlişkisi
4. Ulusal İmmünoterapi ve Onkoloji Kongresi (29.10.2020 – 01.11.2020)
Mahmut Büyükşimşek, Ali Oğul, Semra Paydaş, Özge Yaprak, Suzan Zorludemir, Melek Ergin · Abstract · Oral presentation
- 2020
BAĞ VE YUMUŞAK DOKU SARKOMLARINDA TEK MERKEZ DENEYİMİ
3. GENÇLERLE ONKOLOJİYE BAKIŞ KONGRESİ (13.02.2020 – 16.02.2020)
Ali Oğul, Mahmut Büyükşimşek · Abstract · Oral presentation
- 2019
Evre II ve Evre III Kolon Kanseri Hastalarında D Vitamini Düzeyinin İncelenmesi
V. International Congress on Natural and Health Sciences (13.12.2019 – 15.12.2019)
Ali Oğul · Abstract · Oral presentation
- 2019
YENİ TANI ALMIŞ KANSER HASTALARINA YÖNELİK BİLGİLENDİRME SÜRECİ UYGULAMALARI
International Hippocrates Congress on Medical and Health Sciences (01.03.2019 – 03.03.2019)
Ali Oğul · Abstract · Oral presentation
- 2019
Malignitesi olan hastalarda ilaç yan etkileri ve tiroid fonksiyonları
18th International Eastern Mediterranean Family Medicine Congress (25.04.2019 – 28.04.2019)
Mahmut Büyükşimşek, Hilmi Erdem Sümbül, Ali Oğul · Abstract · Oral presentation
- 2019
LOKAL İLERİ VE METASTATİK MUKOEPİDERMOİD KARSİNOMDA TEK MERKEZ DENEYİMİ
VI. Nadir Tümörler Sempozyumu (22.02.2019 – 24.02.2019)
Ali Oğul, Semra Paydaş · Abstract · Oral presentation
- 2019
LORLATINIB EXPERIENCE IN A CASE WITH NON- SMALL CELL LUNG CANCER (NSCLC): HIGH EFFICACY BUT UNEXPECTED HIGH TOXICITY
23. ULUSAL KANSER KONGRESİ (17.04.2019 – 21.04.2019)
Mahmut Büyükşimşek, Semra Paydaş, Abdullah Evren Yetişir, Cem Mirili, Ali Oğul, Servet Başdoğan · Abstract · Poster
- 2018
AKCİĞER ADENOKARSİNOMUNDA C-MET AMPLİFİKASYONU VE KRİZOTİNİB TEDAVİSİ; OLGU SUNUMU
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Abdullah Evren Yetişir, Semra Paydaş, Mahmut Büyükşimşek, Ali Oğul, Mert Tohumcuoğlu · Abstract · Poster
- 2018
KEMOTERAPİ İLİŞKİLİ PELLAGRA
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Ali Oğul, Semra Paydaş, Cem Mirili, Mahmut Büyükşimşek, Abdullah Evren Yetişir, Mert Tohumcuoğlu, Bilgin Karaalioğlu · Abstract · Poster
- 2018
NİVOLUMAB ERKEN ERİŞİM PROGRAMI: UZUN DÖNEM TAKİP VERİLERİ
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Cem Mirili, Semra Paydaş, İsa Burak Güney, Ali Oğul, Serkan Gökçay, Mahmut Büyükşimşek, Abdullah Evren Yetişir, Mert Tohumcuoğlu, Bilgin Karaalioğlu · Abstract · Poster
- 2018
G-CSF RELATED HEMOPHAGOCYTOSIS IN A CASE WITH LYMHPHOMA
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Bilgin Karaalioğlu, Semra Paydaş, Abdullah Evren Yetişir, Cem Mirili, Elçin İsmayilov, Mahmut Büyükşimşek, Ali Oğul, Emine Kılıç Bağır, Melek Ergin · Abstract · Poster
- 2018
KÜÇÜK HÜCRELİ AKCİĞER KANSERİNDE KHAK NÖTROFİL LENFOSİT ORANI NLO İLE PET CT’DE SAPTANAN METABOLİK PARAMETRELERİNİN PET CT MP PROGNOSTİK ÖNEMİ VE NLO İLE PET CT MP İLİŞKİSİ
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Cem Mirili, Semra Paydaş, İsa Burak Güney, Gülşah Seydaoğlu, Tuba Korkmaz Kapukaya, Ali Oğul, Serkan Gökçay · Abstract · Oral presentation
- 2018
EDİNSEL İMMÜN YETMEZLİKLİ BİR OLGUDA KAPOSİ SARKOMUNUN EŞLİK ETTİĞİ TAFRO SENDROMU
7. Türk Tıbbi Onkoloji Kongresi (21.03.2018 – 25.03.2018)
Mert Tohumcuoğlu, Semra Paydaş, Ali Oğul, Mahmut Büyükşimşek, Abdullah Evren Yetişir, Behice Kurtaran, Melek Ergin, Cem Mirili, Bilgin Karaalioğlu · Abstract · Poster
- 2017
Prephase tedavinin yüksek tümör yükü olan lenfomalı hastalarda tümör lizis sendromunu önlemede etkinliği
Ulusal İmmünoterapi ve Onkoloji kongresi (25.10.2017 – 29.10.2017)
Ali Oğul, Semra Paydaş, Abdullah Evren Yetişir, Cem Mirili, Mahmut Büyükşimşek, Serkan Gökçay · Abstract · Poster
- 2017
Paratiroid karsinomlu, hiperkalsemik hastada perkutan alkol enjeksiyonu seçeneği
Ulusal İmmünoterapi ve Onkoloji kongresi (25.10.2017 – 29.10.2017)
Ali Oğul, Semra Paydaş, Abdullah Evren Yetişir, Mahmut Büyükşimşek, Cem Mirili · Abstract · Poster
- 2017
ANAPLASTİK PLAZMA HÜCRE NEOPLAZİSİ ŞEKLİNDE PREZENTE OLAN POEMS SENDROMU
22. ULUSAL KANSER KONGRESİ (19.04.2017 – 23.04.2017)
Mahmut Büyükşimşek, Abdullah Evren Yetişir, Ali Oğul, Serkan Gökçay, Cem Mirili, Berksoy Şahin · Abstract · Poster
- 2017
İNGUNİAL BÖLGEDE İNFLAMATUAR MYOFİBROBLASTİK TÜMÖR; OLGU SUNUMU
22. ULUSAL KANSER KONGRESİ (19.04.2017 – 23.04.2017)
Abdullah Evren Yetişir, Mahmut Büyükşimşek, Ali Oğul, Serkan Gökçay, Cem Mirili, Berksoy Şahin · Abstract · Poster
- 2017
Renal Primitif Nöroektodermal Tümör; Olgu Sunumu
Ulusal İmmünoterapi ve Onkoloji kongresi (25.10.2017 – 29.10.2017)
Abdullah Evren Yetişir, Semra Paydaş, Mahmut Büyükşimşek, Ali Oğul · Abstract · Poster
- 2017
RAI TEDAVİSİ SONRASI GELİŞEN EOZİNOFİLİK MYELOİD NEOPLAZİ VE LENFOBLASTİK LENFOMA BİRLİKTELİĞİ
22. ULUSAL KANSER KONGRESİ (19.04.2017 – 23.04.2017)
Mahmut Büyükşimşek, Abdullah Evren Yetişir, Ali Oğul, Serkan Gökçay, Cem Mirili, Semra Paydaş · Abstract · Poster
- 2017
The Importance of Parameters: MPV, MPV/Thrombocyte Ratio and Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer
1. Çukurova Hepatoselüler Karsinoma Sempozyumu (10.02.2017 – 11.02.2017)
Ali Oğul, Berksoy Şahin, Ferit Kuşcu, Onur Taktakoğlu, Abdullah Evren Yetişir, Mahmut Büyükşimşek, Cem Mirili, Serkan Gökçay, Mehmet Gökhan Gök, Pınar Kum · Abstract · Oral presentation
- 2017
REAL WORLD EXPERİENCE: NİVOLUMAB EXPANDED ACCESS PROGRAM IN TURKEY
22. ULUSAL KANSER KONGRESİ (19.04.2017 – 23.04.2017)
Cem Mirili, Semra Paydaş, Serkan Gökçay, Ali Oğul, Mahmut Büyükşimşek, Abdullah Evren Yetişir · Abstract · Poster
- 2017
GEBELİKLE İLİŞKİSİZ GESTASYONEL TROFOBLASTİK TÜMÖR:VAKA SUNUMU
22. ULUSAL KANSER KONGRESİ (19.04.2017 – 23.04.2017)
Serkan Gökçay, Berksoy Şahin, Ali Oğul, Cem Mirili, Mahmut Büyükşimşek, Abdullah Evren Yetişir · Abstract · Poster
Book chapters 5
- 2021
Gebelikte Meme Kanserinde Anti-Her2 Tedavilerinin Kullanımı
Gebelikte Onkolojik Yaklaşımlar · Akademisyen Yayınevi
- 2020
Hedgehog Yolağı İnhibisyonunu Sağlayan İlaçlar ve Etki Mekanizmaları
Onkolojide Moleküler Hedefli Tedaviler · Akademisyen Yayınevi
- 2019
Timoma ve Timik Karsinomda Sistemik Tedaviler
Toraks Tümörleri · Akademisyen Yayınevi
- 2019
Malign Plevral Effüzyonların Yönetimi
Onkolojide Özel Konular · Akademisyen Yayınevi
- 2018
Hepatoselüler Kanser Tedavisinde Güncel Yaklaşım
Akademisyen Yayınevi Bilimsel Araştırmalar Kitabı
Awards 3
- 2020Second Prize for Research Article, National Lung Health Congress (Turkey)Akciğer Sağlığı ve Yoğun Bakım Derneği
- 2017First Prize, Dr. İbrahim Türker Research Awards, National Immunotherapy and Oncology Congress (Turkey)Onkoloji ve İmmünoterapi Derneği
- 2016Abstract Award, 3rd National Congress of Immuno-Oncology and Targeted Cancer Therapies (Turkey)İmmüno-Onkoloji Derneği
Clinical trials and projects 9
Investigator in 8 international multicentre clinical trials and principal investigator in 1 national project.
- 2024 –
DESTINY-Gastric04: trastuzumab deruxtecan in HER2-positive metastatic or unresectable gastric / gastroesophageal junction adenocarcinoma, phase 3
International · Investigator · Ongoing
- 2024 –
Comparison of HD204 with reference bevacizumab in metastatic or recurrent non-squamous non-small cell lung cancer, phase 3 equivalence study
International · Investigator · Ongoing
- 2024 –
Zimberelimab (AB122) in first-line treatment of PD-L1-positive non-small cell lung cancer, phase 3
International · Investigator · Ongoing
- 2024
Relationship between eIF5B expression and survival in glioblastoma patients who received adjuvant temozolomide and radiotherapy
National · Principal investigator
- 2024–2025
Long-term follow-up study for volunteers who took part in bintrafusp alfa (M7824) clinical trials
International · Investigator · Completed
- 2017–2025
Study comparing REGN2810 (anti-PD-1) with platinum-based chemotherapy in metastatic non-small cell lung cancer, phase 3
International · Investigator · Completed
- 2017 –
GAMMA-1: first-line andecaliximab and mFOLFOX6 in advanced gastric / gastroesophageal junction adenocarcinoma, phase 3
International · Investigator
- 2015 –
Nab-paclitaxel and atezolizumab in previously untreated triple-negative metastatic breast cancer, phase III (WO29522)
International · Investigator
- 2015–2021
PACIFIC: MEDI4736 (durvalumab) after chemoradiotherapy in stage III unresectable non-small cell lung cancer, phase III
International · Investigator · Completed
Courses and certificates 7
- 2019
Medical Oncology Proficiency Certificate
Turkish Society of Medical Oncology · Antalya
- 2018
Diagnosis, treatment and multidisciplinary management in metastatic colorectal and breast cancer
Oldenburg (international)
- 2018
Update course on gastrointestinal system cancers
TTOD Postgraduate Update Courses · Ankara
- 2017
Applied biostatistics training with IBM SPSS
Adana
- 2016
Update course on head and neck and central nervous system cancers
TTOD Postgraduate Update Courses · İzmir
- 2015
Update course on breast cancer
TTOD Postgraduate Update Courses · Istanbul
- 2013
Applied training programme on preventing invasive device-associated infections
Çukurova University Balcalı Hospital · Adana
Memberships and thesis supervision
- 2015 –
Turkish Society of Medical Oncology
Member · Scientific society
- 2024
Effect of intratumoral heterogeneity index on survival in wild-type metastatic colon adenocarcinoma
Medical specialty thesis supervision · SBÜ Adana Faculty of Medicine, Department of Internal Medicine
Sources: Mersin University APBS · ORCID
Contact
Get in touch for appointments and information
To make an appointment, you can send a WhatsApp message or call +90 530 250 54 85.
You can send your request for a second opinion and your current pathology, imaging and discharge reports via WhatsApp; the evaluation takes place face to face in the outpatient clinic. Process and required documents
The content of this website is for general information only and does not replace an individual medical assessment, diagnosis or treatment recommendation.